Skip to main content
. 2019 Nov 21;14(12):1763–1772. doi: 10.2215/CJN.05910519

Table 1.

Characteristics of patients with incident ESKD in the United States, by Medicare prospective payment system policy period and early peritoneal dialysis experience

Characteristic Overall N=619,126 Prepolicy Cohort: 2006–2010 N=387,115 Postpolicy Cohort: 2011–2013 N=232,011
HD n=350,619 PDa n=36,496 HD n=202,837 PDa n=29,174
Cohort characteristics
 Days observed, mean (SD) 615 (198) 607 (204) 625 (183) 622 (194) 641 (172)
 Censored, N (%) 244,833 (40) 145,418 (42) 18,589 (51) 69,641 (34) 11,235 (39)
Patient characteristics
 Age, mean (SD) 61 (16) 61 (15) 55 (17) 61 (15) 55 (16)
 Male, N (%) 353,727 (57) 199,025 (57) 20,479 (56) 117,419 (58) 16,804 (58)
 Race, N (%)
  White 396,992 (64) 220,586 (63) 26,101 (72) 129,824 (64) 20,481 (70)
  Black 185,293 (30) 109,967 (31) 7953 (22) 60,855 (30) 6518 (22)
  Other 36,841 (6) 20,066 (6) 2442 (7) 12,158 (6) 2175 (8)
 Hispanic ethnicity, N (%) 87,414 (14) 48,649 (14) 4382 (12) 30,452 (15) 3931 (14)
 Employed (full- or part-time), N (%) 77,597 (13) 38,433 (11) 10,143 (28) 20,962 (10) 8059 (28)
 Urban residential status, N (%) 492,730 (80) 280,062 (80) 27,499 (75) 162,771 (80) 22,398 (77)
 Distance to nearest dialysis facility, mean miles (SD)b 4 (7) 4 (7) 6 (12) 3 (6) 5 (12)
 Relative distance to nearest PD facility, mean miles (SD)b 5 (12) 5 (12) 5 (14) 4 (11) 4 (11)
 Region, N (%)
  South 261,662 (42) 146,864 (42) 16,248 (45) 85,340 (42) 13,210 (45)
  Midwest 133,346 (22) 76,494 (22) 7903 (22) 42,869 (21) 6080 (21)
  Northeast 104,349 (17) 61,278 (18) 4850 (13) 34,754 (17) 3467 (12)
  West 119,769 (19) 65,983 (19) 7495 (21) 39,874 (20) 6417 (22)
 Insurance, N (%)c
  Medicare 325,987 (53) 184,971 (53) 13,323 (37) 115,525 (57) 12,168 (42)
  Medicaid 173,113 (28) 100,723 (29) 5909 (16) 61,600 (30) 4881 (17)
  Department of Veterans Affairs 14,176 (2) 7764 (2) 512 (1) 5411 (3) 489 (2)
  Employer group 164,044 (27) 91,041 (26) 16,747 (46) 44,232 (22) 12,024 (41)
  Other 121,901 (20) 72,005 (21) 6963 (19) 37,840 (19) 5093 (18)
  None 55,415 (9) 31,739 (9) 3270 (9) 17,519 (9) 2887 (10)
 Cause of ESKD, N (%)
  Diabetes 289,664 (47) 165,317 (47) 14,928 (41) 97,049 (48) 12,370 (42)
  Hypertension 179,257 (29) 101,296 (29) 8762 (24) 61,497 (30) 7702 (26)
  GN 56,086 (9) 29,656 (9) 6259 (17) 15,501 (8) 4670 (16)
  Other/Missing 94,119 (15) 54,350 (16) 6547 (18) 28790 (14) 4432 (15)
  Unknown
Comorbidities, N (%)d
  Hypertension 538,007 (87) 301,935 (86) 31,457 (86) 178,880 (88) 25,735 (88)
  Diabetes 341,783 (55) 193,327 (55) 16,730 (46) 117,329 (58) 14,397 (49)
  Congestive heart failure 185,094 (30) 113,070 (32) 6331 (17) 60,985 (30) 4708 (16)
  Atherosclerotic heart disease 114,870 (19) 71,700 (20) 5252 (14) 34,577 (17) 3341 (12)
  Peripheral vascular disease 75,976 (12) 47,210 (14) 3232 (9) 23,456 (12) 2078 (7)
Pre-ESKD nephrology care, N (%)
  Yes 375,642 (61) 201,886 (58) 29,641 (81) 120,448 (59) 23,667 (81)
  No 171,393 (28) 106,635 (30) 5001 (14) 55,766 (28) 3991 (14)
  Unknown 72,091 (12) 42,098 (12) 1854 (5) 26,623 (13) 1516 (5)
BMI, kg/m2, mean (SD) 29 (8) 29 (8) 29 (7) 30 (8) 29 (7)
eGFR, ml/min per 1.73 m2, mean (SD)e 10 (6) 10 (6) 10 (5) 10 (6) 10 (5)
Market characteristics (hospital referral region)
 Dialysis facility composition, mean (SD)
  % offering PD in 2006f 39 (15) 38 (15) 40 (16) 41 (15) 43 (15)
  % freestanding facilities 90 (15) 89 (16) 90 (15) 91 (13) 92 (12)
  % for profit 82 (20) 81 (20) 82 (21) 85 (18) 85 (18)
  % chain-affiliated 85 (16) 83 (17) 84 (17) 86 (15) 88 (13)
  % urban location 77 (24) 77 (24) 74 (24) 78 (23) 75 (24)
 Dialysis market competition, mean (SD)g 39 (18) 39 (18) 41 (19) 39 (18) 41 (18)
 Hospital density, mean (SD)h 301 (117) 306 (121) 303 (112) 293 (113) 290 (107)
 % urban general population, mean (SD) 81 (16) 81 (16) 78 (16) 81 (16) 79 (16)
 Per capita income, $1000s, mean (SD) 40 (99) 39 (8) 38 (8) 43 (9) 42 (9)

HD, hemodialysis; PD, peritoneal dialysis; BMI, body mass index; GN, glomerulonephritis.

a

PD modality at any point during the 2-yr follow-up period.

b

Absolute distance to nearest dialysis facility and relative distance (difference) between distance to nearest dialysis facility and distance to nearest dialysis facility that offers PD.

c

Insurance status is not mutually exclusive. Patients can have multiple sources of insurance coverage.

d

Other comorbidities included chronic obstructive pulmonary disease, cerebrovascular disease, inability to ambulate, inability to transfer, other cardiac disease, cancer, drug dependence, and tobacco use, not shown here but described in Supplemental Table 1.

e

Calculation of eGFR is on the basis of the Chronic Kidney Disease Epidemiology Collaboration formula.

f

PD includes continuous ambulatory PD, continuous cyclic PD, and other PD.

g

Measured using the Herfindahl–Hirschman index of dialysis market competition. Higher values correspond to less competition, i.e., more monopolistic markets.

h

Hospital density is defined as the number of community hospital beds per 100,000 people in a hospital referral region.